Centogene N.V. announced a private placement to issue convertible loan for gross proceeds of $30 million on June 27, 2023. The transaction will include participation from new investor, Lifera. The loan will be convertible before 2024 into common stock at a conversion price of $2.20.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.398 USD | +2.05% | -8.29% | -66.83% |
02/04 | Centogene Gets Nasdaq Noncompliance Notice | MT |
19/03 | Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-66.83% | 11.09M | |
+23.37% | 47.02B | |
+49.51% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- CNTG Stock
- News Centogene N.V.
- Centogene N.V. announced that it expects to receive $30 million in funding from Lifera